NKTX
Nkarta, Inc.NASDAQHealthcare$2.32+5.94%ClosedMarket Cap: $165.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.56
P/S
0.00
EV/EBITDA
-2.01
DCF Value
$-0.50
FCF Yield
-53.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-30.0%
ROA
-25.8%
ROIC
-31.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-31.0M | $-27.4M | $-0.37 | — |
| FY 2025 | $0.00 | -Infinity% | $-121.2M | $-104.1M | $-1.41 | — |
| Q3 2025 | $0.00 | NaN% | $-27.3M | $-21.7M | $-0.29 | — |
| Q2 2025 | $0.00 | NaN% | $-27.2M | $-23.0M | $-0.31 | — |
| Q1 2025 | $0.00 | NaN% | $-36.6M | $-32.0M | $-0.43 | — |
| Q4 2024 | $0.00 | NaN% | $-30.9M | $-25.9M | $-0.35 | — |
| FY 2024 | $0.00 | NaN% | $-128.2M | $-108.8M | $-1.60 | — |
| Q3 2024 | $0.00 | NaN% | $-33.8M | $-28.3M | $-0.39 | — |
| Q2 2024 | $0.00 | NaN% | $-30.7M | $-25.0M | $-0.34 | — |
| Q1 2024 | $0.00 | -Infinity% | $-32.8M | $-29.5M | $-0.58 | — |
| Q4 2023 | $0.00 | NaN% | $-31.2M | $-27.8M | $-0.57 | — |
| FY 2023 | $0.00 | -Infinity% | $-131.7M | $-117.5M | $-2.40 | — |